Topoisomerases are enzymes that reduce DNA supercoiling by introducing cuts in DNA strands. TopoGEN recognises the unique details of topoisomerase drug discovery and provides innovative reagents and kits for topoisomerase research and mechanism-based drug development in cancer.
Kits are available to assay for topoisomerases (I, II, IV and gyrase) and Tdp1, to measure topo/DNA interactions in vivo and to identify new topoisomerase drugs. The company also offers a complete line of DNA substrates topo inhibitors, antibodies and kit replenishment reagents.
Phone: 02 9698 2022
Waters BD FACSDiscover A7 Cell Analyzer
The BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with...
Lumiprobe CytoTracer fluorescent cell dyes
The dyes rapidly penetrate cells, form intracellular membrane-impermeable products, and deliver...
Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit
The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...
